September 6, 2007 - While few complications were found last year with implantable cardioverter defibrillators (ICDs), 15 ...
Cordis Endovascular announced, at the 61st Annual Meeting of the Society for Vascular Surgery, the worldwide launch of ...
Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-viscous ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
September 5, 2007 – According to Boston Scientific Corp., results from the TAXUS WOMAN study, a gender specific analysis ...
Siemens Medical Solutions Ultrasound Division’s syngo Arterial Health Package (AHP) application for cardiovascular risk ...
September 6, 2007 – Boston Scientific Corp. announced at the ESC 2007 conference in Vienna, Austria, that results from ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
GE Healthcare Medical Diagnostics’ VISIPAQUE is reportedly the only isosmolar contrast medium (IOCM) available in the U.S. With an osmolality equal to that of blood, VISIPAQUE was designed for patient safety and comfort and is also formulated with sodium and calcium in a ratio equivalent to blood.
September 6, 2007 – The New England Journal of Medicine published the first study to demonstrate a clear superiority of ...
St. Jude Medical Inc. announced that the FDA cleared the ACross Transseptal Access System, a device designed to improve control and simplify the procedure physicians use to access the left atrium during complex cardiac procedures such as atrial fibrillation ablation.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 5, 2007 - Results from a study on acute cardiogenic pulmonary edema, or "fluid on the lung," presented at the ...
September 5, 2007 - Clinical investigators at the European Society of Cardiology Congress 2007 (ESC Congress 2007) ...
September 5, 2007 - The National Institutes of Health has awarded its $5 million Bioengineering Research Partnership ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 5, 2007 - Edwards Lifesciences Corp. announced that it has received CE Mark approval for European commercial ...
September 4, 2007 - Analysis of clinical trials showed the Cypher Sirolimus-eluting coronary stent was associated with ...
September 4, 2007 – At the European Society of Cardiology’s (ESC) annual congress, Royal Philips Electronics ...
September 05, 2007
